The Absence of Stereoselective P-Glycoprotein-mediated Transport of R/S-Verapamil Across the Rat Jejunum
- 1 July 1998
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 50  (7) , 729-735
- https://doi.org/10.1111/j.2042-7158.1998.tb07133.x
Abstract
We have studied the potential stereoselective transport and metabolism of R/Sâverapamil in rat jejunum, inâsitu. A regional singleâpass perfusion of the rat jejunum was performed on 24 rats in six separate groups. The effective permeability (Peff) was assessed for three different concentrations of verapamil, 4, 40 and 400 mg Lâ1. The Peff of each enantiomer was also determined at 400 mg Lâ1 when chlorpromazine (10 mM) was added to the perfusion solution. Two other groups of rats received R/Sâverapamil as an intravenous infusion and the intestinal secretion and metabolism were studied by simultaneously perfusing the jejunum with a control or with chlorpromazine (10 mM) added. The concentrations in the outlet perfusate of each enantiomer of verapamil and norverapamil were assayed with HPLC. R/SâVerapamil is a high permeability drug in the proximal rat small intestine throughout the luminal concentration range studied and complete intestinal absorption was expected. There was an increase of Peff from 0.42 times 10â4 cm sâ1 to 0.80 times 10â4 cm sâ1 (P < 0.05) at concentrations from 4 to 400 mg Lâ1, respectively. The observed concentrationâdependent jejunal Peff and fraction absorbed (P < 0.05) of R/Sâverapamil is consistent with the saturation of an efflux mechanism. When chlorpromazine (a Pâglycoprotein inhibitor/substrate) was added the jejunal Peff increased to 1.47 times 10â4 cm sâ1. There was no difference between the Peff of the two enantiomers in any of these experiments. The efflux of R/Sânorverapamil into the rat jejunum was high after intravenous administration of R/Sâverapamil, suggesting extensive metabolism in the enterocyte. In conclusion, both R/Sâverapamil enantiomers are Pâglycoprotein substrates, but there is no stereoselective transport of R/Sâverapamil in the rat jejunum. The results also suggests that R/Sânorverapamil is formed inside the enterocytes.Keywords
This publication has 25 references indexed in Scilit:
- Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by RifampinHepatology, 1996
- Direct demonstration of small intestinal secretion and site-dependent absorption of the ÎČ-blocker talinolol in humans*Clinical Pharmacology & Therapeutics, 1996
- Comparison Between Permeability Coefficients in Rat and Human JejunumPharmaceutical Research, 1996
- Transport of celiprolol across human intestinal epithelial (Cacoâ2) cells: mediation of secretion by multiple transporters including PâglycoproteinBritish Journal of Pharmacology, 1993
- Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammalsPharmacology & Therapeutics, 1993
- Evidence for an Interaction Between the ÎČ-Blocker Pafenolol and Bile Salts in the Intestinal Lumen of the Rat Leading to Dose-Dependent Oral Absorption and Double Peaks in the Plasma ConcentrationâTime ProfilePharmaceutical Research, 1993
- Dose-Dependent Intestinal Absorption and Significant Intestinal Excretion (Exsorption) of the ÎČ-Blocker Pafenolol in the RatPharmaceutical Research, 1993
- Is the multidrug transporter a flippase?Trends in Biochemical Sciences, 1992
- Regional Jejunal Perfusion, a New in Vivo Approach to Study Oral Drug Absorption in ManPharmaceutical Research, 1992
- Use of laminar flow and unstirred layer models to predict intestinal absorption in the rat.Journal of Clinical Investigation, 1988